國立虎尾科技大學 |

Choroidal Neovascularization

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Choroidal Neovascularization/ edited by Jay Chhablani.
other author:	Chhablani, Jay.
Description:	XVII, 433 p. 171 illus., 159 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Ophthalmology. -
Online resource:	https://doi.org/10.1007/978-981-15-2213-0
ISBN:	9789811522130

Choroidal Neovascularization
Choroidal Neovascularization[electronic resource] /edited by Jay Chhablani. - 1st ed. 2020. - XVII, 433 p. 171 illus., 159 illus. in color.online resource.

Section I: History -- History of choroidal neovascularization (CNV) - initial understanding and development -- Section II: Basics -- Pathogenesis – various proposed mechanisms -- Histopathology – recent understanding in relationship with imaging -- Electron microscopy – update in choroidal changes -- Section III: Clinical classification -- Neovascular age-related macular degeneration (AMD) – clinical features, imaging, protocols and outcomes -- CNV secondary to pathologic myopia – clinical features, imaging and treatment outcomes -- Pachychoroid related CNV – recent updates, imaging and outcomes -- Inflammatory CNV – clinical features, imaging and treatment outcomes -- Dystrophy related CNV – clinical features, imaging and treatment outcomes -- CNV secondary to angioid streaks – clinical features, imaging and treatment protocols -- Idiopathic CNV – clinical features, imaging and treatment outcomes -- CNV associated with idiopathic juxtafoveal telangiectasia – clinical features, imaging and treatment outcomes -- CNV associated with other causes – laser induced, idiopathic intracranial hypertension, choroidal osteoma, trauma, choroidal coloboma, choroidal nevus, etc -- Peripapillary CNVM – overview of various causes, imaging features and treatment outcomes -- Pediatric CNVM – overview of various causes, imaging features and treatment outcomes -- Polypoidal choroidal vasculopathy (PCV) – clinical features, imaging and treatment outcomes -- Section IV: Treatment options -- Anti-VEGF current options – Ranibizumab, Bevacizumab, Aflibercept, Ziv-aflibercept, Conbercept -- Photodynamic therapy – current status in anti-VEGF era -- Surgical intervention – graft, retinal implant, the implantable miniature telescope, surgical removal of CNV, subretinal tissue plasminogen activator -- Section V: Clinical trials -- n-AMD trials – comprehensive overview of PDT and anti-VEGF trials in AMD -- Myopic CNV trials – comprehensive overview of PDT and anti-VEGF trials in AMD -- Non-AMD CNV trials – comprehensive overview of various trials in non-AMD related CNV causes -- PCV trials – comprehensive overview of PDT and anti-VEGF trials in PCV -- Section VI: Future directions -- Stem cells in AMD – current status and future expectations -- Newer molecules – newer targets in CNV and the upcoming research -- Radiotherapy – role of radiotherapy and clinical trials -- Other options – role of subthreshold laser, and other therapies in CNV -- Section VII: Rehabilitation -- Low vision aids -- Peripheral vision development – newer approach for macular diseases -- Monitoring techniques – advanced home monitoring techniques and initial experience.

The book discusses all aspects of choroidal neovascularization (CNV), including the basics, clinical conditions associated with CNV, clinical trials related to CNV, future directions and rehabilitation. The first section covers the pathogenesis, proposed mechanisms, disease models, histopathology and electronmicroscopy. The next section explores CNV secondary to various clinical conditions, such as age-related macular degeneration (AMD), myopia, and less common conditions like choroidal osteoma. The book also covers clinical features, imaging characteristics, and treatment approaches, as well as clinical trials in CNV conditions with recent updates. Lastly, it features chapters on stem cell therapy, gene therapy, new molecules, and lasers, as well as a section on rehabilitation, which addresses home monitoring and low vision aids. This book is intended for retina specialists, retina fellows and general ophthalmologists.

ISBN: 9789811522130

Standard No.: 10.1007/978-981-15-2213-0doiSubjects--Topical Terms:

644487
Ophthalmology.

LC Class. No.: RE1-994

Dewey Class. No.: 617.7

Choroidal Neovascularization
LDR:04944nam a22003975i 4500 001 1018177
003 DE-He213
005 20200731180123.0
007 cr nn 008mamaa
008 210318s2020 si | s |||| 0|eng d
020 $a 9789811522130 $9 978-981-15-2213-0
024 7 $a 10.1007/978-981-15-2213-0 $2 doi
035 $a 978-981-15-2213-0
050 4 $a RE1-994
072 7 $a MJQ $2 bicssc
072 7 $a MED063000 $2 bisacsh
072 7 $a MJQ $2 thema
082 0 4 $a 617.7 $2 23
245 1 0 $a Choroidal Neovascularization $h [electronic resource] / $c edited by Jay Chhablani.
250 $a 1st ed. 2020.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a XVII, 433 p. 171 illus., 159 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Section I: History -- History of choroidal neovascularization (CNV) - initial understanding and development -- Section II: Basics -- Pathogenesis – various proposed mechanisms -- Histopathology – recent understanding in relationship with imaging -- Electron microscopy – update in choroidal changes -- Section III: Clinical classification -- Neovascular age-related macular degeneration (AMD) – clinical features, imaging, protocols and outcomes -- CNV secondary to pathologic myopia – clinical features, imaging and treatment outcomes -- Pachychoroid related CNV – recent updates, imaging and outcomes -- Inflammatory CNV – clinical features, imaging and treatment outcomes -- Dystrophy related CNV – clinical features, imaging and treatment outcomes -- CNV secondary to angioid streaks – clinical features, imaging and treatment protocols -- Idiopathic CNV – clinical features, imaging and treatment outcomes -- CNV associated with idiopathic juxtafoveal telangiectasia – clinical features, imaging and treatment outcomes -- CNV associated with other causes – laser induced, idiopathic intracranial hypertension, choroidal osteoma, trauma, choroidal coloboma, choroidal nevus, etc -- Peripapillary CNVM – overview of various causes, imaging features and treatment outcomes -- Pediatric CNVM – overview of various causes, imaging features and treatment outcomes -- Polypoidal choroidal vasculopathy (PCV) – clinical features, imaging and treatment outcomes -- Section IV: Treatment options -- Anti-VEGF current options – Ranibizumab, Bevacizumab, Aflibercept, Ziv-aflibercept, Conbercept -- Photodynamic therapy – current status in anti-VEGF era -- Surgical intervention – graft, retinal implant, the implantable miniature telescope, surgical removal of CNV, subretinal tissue plasminogen activator -- Section V: Clinical trials -- n-AMD trials – comprehensive overview of PDT and anti-VEGF trials in AMD -- Myopic CNV trials – comprehensive overview of PDT and anti-VEGF trials in AMD -- Non-AMD CNV trials – comprehensive overview of various trials in non-AMD related CNV causes -- PCV trials – comprehensive overview of PDT and anti-VEGF trials in PCV -- Section VI: Future directions -- Stem cells in AMD – current status and future expectations -- Newer molecules – newer targets in CNV and the upcoming research -- Radiotherapy – role of radiotherapy and clinical trials -- Other options – role of subthreshold laser, and other therapies in CNV -- Section VII: Rehabilitation -- Low vision aids -- Peripheral vision development – newer approach for macular diseases -- Monitoring techniques – advanced home monitoring techniques and initial experience.
520 $a The book discusses all aspects of choroidal neovascularization (CNV), including the basics, clinical conditions associated with CNV, clinical trials related to CNV, future directions and rehabilitation. The first section covers the pathogenesis, proposed mechanisms, disease models, histopathology and electronmicroscopy. The next section explores CNV secondary to various clinical conditions, such as age-related macular degeneration (AMD), myopia, and less common conditions like choroidal osteoma. The book also covers clinical features, imaging characteristics, and treatment approaches, as well as clinical trials in CNV conditions with recent updates. Lastly, it features chapters on stem cell therapy, gene therapy, new molecules, and lasers, as well as a section on rehabilitation, which addresses home monitoring and low vision aids. This book is intended for retina specialists, retina fellows and general ophthalmologists.
650 0 $a Ophthalmology. $3 644487
700 1 $a Chhablani, Jay. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1283966
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811522123
776 0 8 $i Printed edition: $z 9789811522147
776 0 8 $i Printed edition: $z 9789811522154
856 4 0 $u https://doi.org/10.1007/978-981-15-2213-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)